جعفرزاده، میرقاسم و غفوری، زینب (1395). جایگاه دفاع استفادة آزمایشی از اختراع در دعوای نقض حق اختراع: استثنایی مطلق یا مقید. تحقیقات حقوقی، ش 80، 157 ـ 186.
عزیزی مرادپور، حمید (1399). تأملی بر مادة 30 موافقتنامة تریپس و درسهایی از رویة قضایی سازمان جهانی تجارت. پژوهش حقوق خصوصی، د 1، ش 1، 61 ـ 75.
نیاورانی، صابر و جاوید، احسان (1395). حق دسترسی به داروهای اساسی در چارچوب موافقتنامة تریپس و چالش حمایت از حق بینالمللی بشر بر سلامت. مجلة حقوقی بینالمللی، ش 54، 29 ـ 58.
Ashok, A. (2022). Bolar Exemption as a Means for Easier Access to Medicine on Human Rights in Health Care.
On Human Rights in Health Care, 37-43. Available at SSRN:
https://ssrn.com/abstract=4471556
Adugna, A. B. (2021). The Place of Bolar Exception under Ethiopian Patent Law: The Need for Reform. Bahir Dar University Journal of Law, Vol. 12, No. 1, 1-26.
Bently, L. et al. (2010). Exclusions from Patentability and Exceptions and Limitations to Patentees’ Rights.
WIPO: Standing Committee on the Law of Patents, Current Legal Problems, Vol. 64, No. 1, 315-347. DOI:
10.1093/clp/cur011
Chawla, G. (2015). Shielding Patent Attacks: A Peek into the Defences and Exceptions to a Patent Infringement Suit. National Law School Journal, Vol. 13, Iss.1, Article 4., 77-107. Available at: https://repository.nls.ac.in/nlsj/vol13/iss1/4
Contreras, J. L. & Jacob, M. (2017). Patent pledges: global perspectives on patent law’s private ordering frontier. Edward Elgar Publishing.
Correa, M. C. (2005). The International Dimension of the Research Exception. 1-66. Available at: https://www.researchgate.net/publication/265320959_The_International_Dimension_of_the_Research_Exception%27
Correa, M. C. (2016). The Bolar Exception: Legislative Models and Drafting Options. Research Paper. Switzerland: South Centre.
Ganslandt, M. & Maskus, K. E., (2004). Parallel Import and the Pricing of Pharmaceutical Products: Evidence from the European Union. IUI Working Paper, No. 622, The Research Institute of Industrial Economics (IUI), Stockholm.
Gurgula, O. & Lee, W. H., (2021). COVID-19, IP and Access: Will the Current System of Medical Innovation and Access to Medicines Meet Global Expectations?. Journal of Generic Medicine, Vol. 17, Issue. 2, 61–70.
Li, P. (2021). Bolar Exemption of the TRIPS Flexibilities: A comparative analysis between the US, Finland and China, of patenting pharmaceuticals and access to vaccines during COVID-19. Stockholm University.
Lidgard, H. H. (2008). Protecting Inventions and Promoting Innovation – A Difficult Act of Balance: A Study of the Experimental Use Exception and the Research Tool Issue. Master thesis, University of Lund, Madeleine Claesson.
Liu, K. C. (2019). Innovation, Economic Development, and Intellectual Property in India and China: Comparing Six Economic Sectors, ARCIALA Series on Intellectual Assets and Law in Asia. Springer Open.
Milenkovich, N. (1999). Deleting the Bolar Amendment to the Hatch-Waxman Act: Harmonizing Pharmaceutical Patent Protection in a Global Village. The John Marshall Law Review, Vol. 30, Issue. 3, 751-778.
Misati, E. & Adachi, K, (2010). The Research and Experimentation Exceptions in Patent Law: Jurisdictional Variations and the WIPO Development Agenda. UNCTAD- ICTSD Project on IPRs and Sustainable Development policy. UNCTAD: Available at https://unctad.org/system/files/official-document/iprs_in20102_en.pdf (Last accessed on 13 June 2021)
Munoz Tellez, V. (2022). Bolar Exception: Access to Medicines and Vaccines Implementing Flexibilities Under Intellectual Property Law, By: Correa, C. M. & Hilty, R. M., Springer International Publishing: https://doi.org/10.1007/978-3-030-83114-1
Pashkov, V. M., Golovanova, L. A., & Olefir, A. A. (2016). The impact of the Legal Regime of Intellectual Property Protection in the Pharmaceutical Market. Wiadomosci Lekarskie, tom LXIX, nr 3 (cz.II), 582-586.
Wested, J. & Minssen, T. (2018). Research and Bolar Exemptions in the U.S. and Europe:
Recent Developments and Possible Scenarios, 1-11. Available at: SSRN:
https://ssrn.com/abstract=3236127
)